|Last Price||Today's Change||52-Week Range||Trading Volume|
|56.26||0.00 (0.00%)||44.60 - 58.14||215.3 thousand (Below Avg)|
Market data as of 12:00AM 04/16/14. Quotes are delayed by at least 15 min.
FDA Approves Merck’s GRASTEK® (Timothy Grass Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Grass Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Children and Adults
04/14/2014 5:59 PM ET